SOCS5 (suppressor of cytokine signaling 5) is a negative regulator of cytokine signaling that functions through multiple mechanisms to control cellular responses and disease processes. SOCS5 acts as a classical feedback inhibitor by suppressing JAK-STAT signaling pathways, particularly JAK2/STAT3, which is crucial for controlling inflammatory responses and cell proliferation 123. The protein also functions as part of an E3 ubiquitin ligase complex, mediating proteasomal degradation of target proteins including STAT1, thereby modulating transcriptional programs 4. SOCS5 plays important roles in immune regulation by inhibiting IL-4 signaling pathways that promote Th2 differentiation, while supporting anti-inflammatory responses 5. Disease relevance includes cancer progression, where SOCS5 downregulation enhances JAK-STAT activation and accelerates T-cell acute lymphoblastic leukemia progression 3, and prostate cancer growth 6. Conversely, SOCS5 upregulation provides protective effects in osteoarthritis by inhibiting cartilage degeneration 2. Clinically, SOCS5 expression is dysregulated in various conditions including periodontitis 7, allergic disorders 5, and cardiovascular disease 1, with epigenetic silencing via DNA methylation contributing to pathogenesis 3. These findings establish SOCS5 as a critical regulator of cytokine signaling with therapeutic potential across multiple disease contexts.